Literature DB >> 26623043

Characteristics of colorectal tumours in asymptomatic patients with negative immunochemical faecal occult blood test results.

Kunihiko Wakamura1, Shin-Ei Kudo1, Hideyuki Miyachi1, Kenta Kodama1, Seiko Hayashi1, Yasuharu Maeda1, Yushi Ogawa1, Yuta Kouyama1, Shin-Ichi Kataoka1, Kazuki Kato1, Katsuro Ichimasa1, Masashi Misawa1, Yuichi Mori1, Toyoki Kudo1, Takemasa Hayashi1, Fumio Ishida1, Shogo Ohkoshi2.   

Abstract

The immunochemical faecal occult blood test (iFOBT) is a simple, non-invasive colorectal cancer (CRC) screening method for reducing CRC-related mortality. However, the sensitivity of iFOBT is imperfect and certain colonic neoplasms that require removal may be missed. The aim of this study was to investigate the incidence and characteristics of CRC in asymptomatic, iFOBT-negative patients who underwent opportunistic screening. A total of 919 subclinical patients (276 iFOBT-positive and 643 iFOBT-negative) in the health screening program of our hospital underwent total colonoscopy (TCS) within 2 years after iFOBT. The patients were divided into an iFOBT-positive and an iFOBT-negative group and the TCS findings were compared between the two groups. Although the incidence of advanced neoplasia (CRC, high-grade dysplasia, adenoma sized ≥10 mm and tubulovillous adenoma) was significantly higher in the iFOBT-positive group, these lesions were also found in 6.3% of iFOBT-negative patients. The lesions tended to be proximally located and non-protruding. In conclusion, screening with iFOBT remains clinically significant. However, colonoscopy is indispensable for reducing the incidence and mortality of CRC.

Entities:  

Keywords:  advanced adenoma; advanced neoplasia; asymptomatic patient; colonoscopy; colorectal cancer screening; immunochemical faecal occult blood test; opportunistic screening

Year:  2015        PMID: 26623043      PMCID: PMC4534872          DOI: 10.3892/mco.2015.591

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  35 in total

Review 1.  Screening for colorectal cancer: current status in Japan.

Authors:  H Saito
Journal:  Dis Colon Rectum       Date:  2000-10       Impact factor: 4.585

Review 2.  Pit pattern in colorectal neoplasia: endoscopic magnifying view.

Authors:  S Kudo; C A Rubio; C R Teixeira; H Kashida; E Kogure
Journal:  Endoscopy       Date:  2001-04       Impact factor: 10.093

Review 3.  The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002.

Authors: 
Journal:  Gastrointest Endosc       Date:  2003-12       Impact factor: 9.427

Review 4.  Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  David A Lieberman; Douglas K Rex; Sidney J Winawer; Francis M Giardiello; David A Johnson; Theodore R Levin
Journal:  Gastroenterology       Date:  2012-07-03       Impact factor: 22.682

5.  Pragmatic classification of superficial neoplastic colorectal lesions.

Authors:  René Lambert; Shin Ei Kudo; Michael Vieth; John I Allen; Hiroaki Fujii; Takahiro Fujii; Hiroshi Kashida; Takahisa Matsuda; Masaki Mori; Hiroshi Saito; Tadakazu Shimoda; Shinji Tanaka; Hidenobu Watanabe; Joseph J Sung; Andrew D Feld; John M Inadomi; Michael J O'Brien; David A Lieberman; David F Ransohoff; Roy M Soetikno; Ann Zauber; Claudio Rolim Teixeira; Jean Francois Rey; Edgar Jaramillo; Carlos A Rubio; Andre Van Gossum; Michael Jung; Jeremy R Jass; George Triadafilopoulos
Journal:  Gastrointest Endosc       Date:  2009-10-31       Impact factor: 9.427

6.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.

Authors:  J D Hardcastle; J O Chamberlain; M H Robinson; S M Moss; S S Amar; T W Balfour; P D James; C M Mangham
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.

Authors:  Enrique Quintero; Antoni Castells; Luis Bujanda; Joaquín Cubiella; Dolores Salas; Ángel Lanas; Montserrat Andreu; Fernando Carballo; Juan Diego Morillas; Cristina Hernández; Rodrigo Jover; Isabel Montalvo; Juan Arenas; Eva Laredo; Vicent Hernández; Felipe Iglesias; Estela Cid; Raquel Zubizarreta; Teresa Sala; Marta Ponce; Mercedes Andrés; Gloria Teruel; Antonio Peris; María-Pilar Roncales; Mónica Polo-Tomás; Xavier Bessa; Olga Ferrer-Armengou; Jaume Grau; Anna Serradesanferm; Akiko Ono; José Cruzado; Francisco Pérez-Riquelme; Inmaculada Alonso-Abreu; Mariola de la Vega-Prieto; Juana Maria Reyes-Melian; Guillermo Cacho; José Díaz-Tasende; Alberto Herreros-de-Tejada; Carmen Poves; Cecilio Santander; Andrés González-Navarro
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

8.  Association of colonoscopy and death from colorectal cancer.

Authors:  Nancy N Baxter; Meredith A Goldwasser; Lawrence F Paszat; Refik Saskin; David R Urbach; Linda Rabeneck
Journal:  Ann Intern Med       Date:  2008-12-15       Impact factor: 25.391

9.  Colorectal tumours and pit pattern.

Authors:  S Kudo; S Hirota; T Nakajima; S Hosobe; H Kusaka; T Kobayashi; M Himori; A Yagyuu
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

10.  Effect of screening colonoscopy on colorectal cancer incidence and mortality.

Authors:  Charles J Kahi; Thomas F Imperiale; Beth E Juliar; Douglas K Rex
Journal:  Clin Gastroenterol Hepatol       Date:  2009-01-11       Impact factor: 11.382

View more
  2 in total

1.  Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis.

Authors:  Tobias Niedermaier; Yesilda Balavarca; Hermann Brenner
Journal:  Am J Gastroenterol       Date:  2020-01       Impact factor: 12.045

2.  The Value of Multi-targeted Fecal DNA Methylation Detection for Colorectal Cancer Screening in a Chinese Population.

Authors:  Heiying Jin; Jun Wang; Chunxia Zhang
Journal:  J Cancer       Date:  2021-01-15       Impact factor: 4.478

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.